Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Van Cutsem

Showing results (101-110 of 499) with videos related to

Pageof 50
Sort By:
ESMO Open|December 7, 2017
QTWiST analysis of the RECOURSE trial of trifluridine/tipiracil in metastatic colorectal cancerJosep Tabernero, Eric Van Cutsem, Atsushi Ohtsu, et al.
Annals of Surgical Oncology|September 13, 2017
External Validation of the Prognostic Nomogram (COMPASS) for Patients with Peritoneal Carcinomatosis of Colorectal CancerKarel Demey, Albert Wolthuis, Anthony de Buck van Overstraeten, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2012
Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trialsCarsten Bokemeyer, Eric Van Cutsem, Philippe Rougier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 11, 2023
<sup>18</sup>F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical UseHannes Leupe, Stephen Ahenkorah, Jeroen Dekervel, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2011
Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary resultsMaarten Lambrecht, Vincent Vandecaveye, Frederik De Keyzer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Model-based prediction of phase III overall survival in colorectal cancer on the basis of phase II tumor dynamicsLaurent Claret, Pascal Girard, Paulo M Hoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2009
Tissue biomarker development in a multicentre trial context: a feasibility study on the PETACC3 stage II and III colon cancer adjuvant treatment trialFred T Bosman, Pu Yan, Sabine Tejpar, et al.
Journal of Computer Assisted Tomography|April 19, 2003
Stool tagging applied in thin-slice multidetector computed tomography colonographyMaarten Thomeer, Iacopo Carbone, Hilde Bosmans, et al.
Communications Medicine|November 18, 2025
Progression-free survival for unresectable non-metastatic locally advanced pancreatic cancer after surgical microwave ablation plus durvalumab and tremelimumab: phase-2 non-randomized prospective clinical trialHalit Topal, Tom Venken, Ayse Bassez, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2013
Improving outcomes in colorectal cancer: where do we go from here?Eric Van Cutsem, Josep Maria Borràs, Antoni Castells, et al.
Pageof 50

Showing results (101-110 of 499) with videos related to

Sort By:
Pageof 50
ESMO Open|December 7, 2017
QTWiST analysis of the RECOURSE trial of trifluridine/tipiracil in metastatic colorectal cancerJosep Tabernero, Eric Van Cutsem, Atsushi Ohtsu, et al.
Annals of Surgical Oncology|September 13, 2017
External Validation of the Prognostic Nomogram (COMPASS) for Patients with Peritoneal Carcinomatosis of Colorectal CancerKarel Demey, Albert Wolthuis, Anthony de Buck van Overstraeten, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2012
Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trialsCarsten Bokemeyer, Eric Van Cutsem, Philippe Rougier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 11, 2023
<sup>18</sup>F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical UseHannes Leupe, Stephen Ahenkorah, Jeroen Dekervel, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2011
Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary resultsMaarten Lambrecht, Vincent Vandecaveye, Frederik De Keyzer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Model-based prediction of phase III overall survival in colorectal cancer on the basis of phase II tumor dynamicsLaurent Claret, Pascal Girard, Paulo M Hoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2009
Tissue biomarker development in a multicentre trial context: a feasibility study on the PETACC3 stage II and III colon cancer adjuvant treatment trialFred T Bosman, Pu Yan, Sabine Tejpar, et al.
Journal of Computer Assisted Tomography|April 19, 2003
Stool tagging applied in thin-slice multidetector computed tomography colonographyMaarten Thomeer, Iacopo Carbone, Hilde Bosmans, et al.
Communications Medicine|November 18, 2025
Progression-free survival for unresectable non-metastatic locally advanced pancreatic cancer after surgical microwave ablation plus durvalumab and tremelimumab: phase-2 non-randomized prospective clinical trialHalit Topal, Tom Venken, Ayse Bassez, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2013
Improving outcomes in colorectal cancer: where do we go from here?Eric Van Cutsem, Josep Maria Borràs, Antoni Castells, et al.
Pageof 50